Media.Player

Three-Dimensional Cell Adhesion Matrix

Technology Benefits

Synthetic biomaterial scaffolds with defined bioactive molecular recognition elements Fine-tunable mechanical properties Purely synthetic and well-characterized reproducible and localized investigation of cell response to biochemical cues

Technology Application

Stem cell maintenance, directed-differentiation, transplant and engraftment Eliciting morphogenic patterns observed in commercially available laminin-rich chemically undefined extracellular matrices Stem cell maintenance, directed-differentiation, transplant and engraftment 3D cell culture Culturing of cognate integrin-expressing tissue types including, but not limited to: endothelial cells embryonic stem cells hematopoietic stem cells and mesenchymal stem cells both non-malignant and malignant human mammary epithelial cells human colon adenocarcinoma

Detailed Technology Description

Researchers at the University of California, Davis have invented a series of novel, bioactive, purely synthetic and "made-to-order" cell adhesion matrices which incorporate molecular recognition elements such as cell surface integrin receptor ligands. These biodegradable and biocompatible nanofibrous matrices are advantageous for three-dimensional (3D) tissue culture and tissue engineering. They are comprised of high molecular weight polyvinyl alcohol (PVA) scaffolds functionalized with high-affinity cell adhesion ligands against naturally expressed or cell-transfected integrins, and cross-linked via cyclic complexation of boronic acid crosslinkers with polyhydroxyls on PVA. By using a number of biocompatible modified polymers, researchers can fine-tune the crosslink density and mechanical properties of the matrices. Cell incorporation is achieved by simultaneous encapsulation of cells in situ within the forming matrices, which occurs rapidly at room temperature and physiological pH. Alternatively, cells can be seeded and maintained in culture atop a pre-formed matrix. Extracellular matrices suitable for 3D culture of different cell types can be made to order by combinatorially incorporating a number of molecular recognition elements, such as ligands which target cell-expressed integrins, into the matrix. Finally, crosslinking of the bioactive PVA scaffolds is reversible on demand by the addition of a cis-diol competitor such as fructose, facilitating non-enzymatic degradation of the hydrogel matrix and rapid extraction of cells from 3D culture for other biological applications.

Application No.

9296988

Others

Related Technologies

• Ligands for Alpha-4-Beta-1 Integrin

Additional Technologies by these Inventors

• Ligands for Alpha-4-Beta-1 Integrin
• A Novel RGD-Containing Cyclic Peptide for use in Cancer Imaging and as a Targeted-Therapy Ligand
• Functional Illumination in Living Cells
• Nanoparticles for Drug Delivery, Tissue Targeting and Imaging Analysis
• Nanoporphyrin Nanoparticles for Combination Phototherapy and Drug Delivery to Infantile Hemangiomas
• Early Detection of Ovarian Cancer Using Markers to Short Chain Carbohydrates
• PVA Nanocarrier System for Controlled Drug Delivery
• Site-Specific Ligation and Compound Conjugation to Existing Antibodies
• Novel Solid Tumor Chemodrug LLS2
• High Throughput Label-Free One-Bead-One-Compound (OBOC) Screening Assay
• Ligands for Improved Angiogenesis and Endothelialization of Blood Contacting Devices
• Proteoglycan Mimetics For Enhanced Wound Healing Angiogenesis And Vascular Repair

Tech ID/UC Case

19575/2009-700-0

Related Cases

2009-700-0

*Abstract

A novel cell adhesion matrix incorporating molecular recognition elements for tissue engineering.

*IP Issue Date

Mar 29, 2016

*Principal Investigator

Name: Kit Lam

Department:

Name: Juntao Luo

Department:

Name: Ekema Onofiok

Department:

Country/Region

USA